SynaptixBio

About:

SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.

Website: https://www.synaptixbio.com

Top Investors: Innovate UK

Description:

SynaptixBio is developing lifesaving therapies for severe leukodystrophies. The company enables the translation of ground-breaking research in TUBB4a Leukodystrophy into a transformative therapy. Their updated news is imported into the website. The customer queries are addressed through an online form.

Total Funding Amount:

13.5M GBP

Headquarters Location:

Oxford, Oxfordshire, United Kingdom

Founded Date:

2021-01-01

Founders:

Bent Jakobsen, Dan Williams, Michelle Teng

Number of Employees:

1-10

Last Funding Date:

2024-08-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai